Using a data-driven approach to define post-COVID conditions in US electronic health record data

• Kathleen M. Andersen ,

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: kathleen.andersen@pfizer.com

  Affiliation Vaccines Real World Evidence, Pfizer Inc, New York, New York, United States of America

  https://orcid.org/0000-0003-2670-800X

  ⨯
• Farid L. Khan ,

  Contributed equally to this work with: Farid L. Khan, Peter W. Park

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Global Medical Affairs, Pfizer Inc, New York, New York, United States of America

  ⨯
• Peter W. Park ,

  Contributed equally to this work with: Farid L. Khan, Peter W. Park

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Global Medical Affairs, Pfizer Inc, New York, New York, United States of America

  ⨯
• Timothy L. Wiemken,

  Roles Methodology, Writing – review & editing

  Affiliation Global Medical Affairs, Pfizer Inc, New York, New York, United States of America

  ⨯
• Birol Emir,

  Roles Methodology, Writing – review & editing

  Affiliation Global Biometrics and Data Management, Pfizer Inc, New York, New York, United States of America

  ⨯
• Deepa Malhotra,

  Roles Methodology, Writing – review & editing

  Affiliation Vaccines Real World Evidence, Pfizer Inc, New York, New York, United States of America

  ⨯
• Tuka Alhanai,

  Roles Formal analysis, Methodology, Writing – review & editing

  Affiliation Ghamut Corporation, East Lansing, Michigan, United States of America

  ⨯
• Mohammad M. Ghassemi,

  Roles Formal analysis, Methodology, Writing – review & editing

  Affiliation Ghamut Corporation, East Lansing, Michigan, United States of America

  ⨯
• Leah J. McGrath

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Vaccines Real World Evidence, Pfizer Inc, New York, New York, United States of America

  ⨯